CHEMOTHERAPY FOR RECURRENT AND METASTATIC CERVICAL-CANCER WITH STANDARD-DOSE METHOTREXATE-LEUCOVORIN, BLEOMYCIN AND CISPLATINUM

被引：0
作者：
VOGL, SE
SELTZER, V
CAMACHO, F
DAVIS, TE
机构：
[1] WISCONSIN CLIN CANC CTR,MADISON,WI
[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED,BRONX,NY 10461
[3] SUNY STONY BROOK,STONY BROOK,NY 11794
来源：
JOURNAL OF REPRODUCTIVE MEDICINE | 1986年 / 31卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：327 / 329
页数：3
相关论文
共 50 条
  • [21] CONCURRENT WEEKLY CISPLATINUM AND RADIOTHERAPY IN ADVANCED CERVICAL-CANCER - A PRELIMINARY DOSE ESCALATING TOXICITY STUDY
    TWIGGS, LB
    POTISH, RA
    MCINTYRE, S
    ADCOCK, LL
    SAVAGE, JE
    PREM, KA
    GYNECOLOGIC ONCOLOGY, 1986, 24 (02) : 143 - 148
  • [22] Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer
    Eskander, Ramez N.
    Tewari, Krishnansu S.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (04) : 314 - 321
  • [23] EFFICACY OF ADJUVANT CHEMOTHERAPY IN METASTATIC CERVICAL-CANCER - A PILOT-STUDY
    KEMNITZ, T
    KRAFFT, W
    GLASER, F
    SCHIRMER, A
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 688 - 689
  • [24] Prognostic value of Her2 overexpression in patients with metastatic breast cancer treated with standard-dose chemotherapy or high-dose consolidation chemotherapy
    Bengala, C
    Guarneri, V
    Salvadori, B
    Landucci, E
    Donati, S
    Orlandini, C
    Campani, D
    Collecchi, P
    Bevilacqua, G
    Conte, PF
    BONE MARROW TRANSPLANTATION, 2003, 31 : S36 - S36
  • [25] HIGH-DOSE METHOTREXATE WITH LEUCOVORIN RESCUE, VINBLASTINE, AND BLEOMYCIN WITH OR WITHOUT TAMOXIFEN IN METASTATIC RENAL-CELL CARCINOMA
    BELL, DR
    ARONEY, RS
    FISHER, RJ
    LEVI, JA
    CANCER TREATMENT REPORTS, 1984, 68 (04): : 587 - 590
  • [26] RESPONSE RATE AND CELL-CYCLE CHANGES DUE TO INTRAARTERIAL INFUSION CHEMOTHERAPY WITH CISPLATIN AND BLEOMYCIN FOR LOCALLY RECURRENT UTERINE CERVICAL-CANCER
    KIGAWA, J
    KANAMORI, Y
    ISHIHARA, H
    MINAGAWA, Y
    IWAMOTO, K
    TERAKAWA, N
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (06): : 474 - 479
  • [27] A PHASE-II TRIAL OF IFOSFAMIDE, 5-FLUOROURACIL, AND LEUCOVORIN IN RECURRENT UTERINE CERVICAL-CANCER
    STORNES, I
    MEJLHOLM, I
    JAKOBSEN, A
    GYNECOLOGIC ONCOLOGY, 1994, 55 (01) : 123 - 125
  • [28] Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review
    Hirte, H. W.
    Strychowskyz, J. E.
    Oliverz, T.
    Fung-Kee-Fung, M.
    Elit, L.
    Oza, A. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (06) : 1194 - 1204
  • [29] Chemotherapy in recurrent and metastatic cervical cancer: single agent versus combination chemotherapy
    Kumar, L
    Pokharel, YH
    Kumar, S
    Singh, R
    Rath, GK
    Kochupillai, V
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1225 - 1228
  • [30] The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer
    Tambaro, R
    Scambia, G
    Di Maio, M
    Pisano, C
    Barletta, E
    Iaffaioli, VR
    Pignata, S
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 52 (01) : 33 - 44
12345